VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 112 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $640,000 | +57.2% | 33,458 | -22.8% | 0.01% | -41.7% |
Q4 2018 | $407,000 | +230.9% | 43,317 | +566.6% | 0.01% | +500.0% |
Q3 2018 | $123,000 | -70.2% | 6,498 | -69.2% | 0.00% | -75.0% |
Q2 2018 | $413,000 | +7.8% | 21,122 | +3.6% | 0.01% | -11.1% |
Q1 2018 | $383,000 | – | 20,380 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |